CA9 抗体 (C-Term)
Quick Overview for CA9 抗体 (C-Term) (ABIN363423)
抗原
See all CA9 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 400-500, C-Term
- 
                                            特异性
- Reacts with CA IX from human, mouse rat and canine
- 
                                            纯化方法
- Antigen affinity purified
- 
                                            免疫原
- Synthetic peptide derived from Cter domain of the human CA IX (within residues 400-500)
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        Working dilution: Optimal dilution should be determined by the end user. 
 The following are guidelines only :
 ICC/IF1:1000 IHC 1:1000 WB1:1000
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 1 mg/mL
- 
                                            缓冲液
- Tris-citrate/phosphate, ( pH 7-8) buffer, Sodium azide 0.1 %
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C
- 
                                            储存方法
- Store at 4°C. Do not freeze.
 
- 
                                            
- 
    - CA9 (Carbonic Anhydrase IX (CA9))
- 
                                            别名
- Carbonic Anhydrase 9
- 
                                            背景
- Interfere in the conversion of CO2 and H2O into carbonic acid, protons and bicaronate ions. Marker of hypoxia.
- 
                                            基因ID
- 768
 抗原
- 
                    
 
                                     
                                     
                                    